US Patent

US9580427 — Kinase inhibitors

Composition of Matter · Assigned to University of California San Diego UCSD · Expires 2033-03-01 · 7y remaining

Vulnerability score 17/100 Ironclad — strong claim type, well-established, deep family

What this patent protects

This patent protects compounds with a specific structure, such as Formula (XI), and methods of using them to inhibit kinases.

USPTO Abstract

Provided herein are compounds such as the compounds having the structure of Formula (XI) and methods of using the same, such as methods of inhibiting kinases.

Drugs covered by this patent

Patent Metadata

Patent number
US9580427
Jurisdiction
US
Classification
Composition of Matter
Expires
2033-03-01
Drug substance claim
Yes
Drug product claim
Yes
Assignee
University of California San Diego UCSD
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.